Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Rapport Therapeutics, Inc. (NASDAQ: RAPP)
RAPP Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-17.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
32.30%
RAPP Stock Analysis
RAPP
PE Ratio:
RAPP
PEG Ratio:
Not Available
RAPP
Forward EPS Growth (12 month):
0.00%
RAPP
PS Ratio:
67.5
RAPP
PSG Ratio:
Not Available
RAPP
Forward Revenue Growth (12 month):
0.00%
RAPP Articles
No data was found